Skip to content

Advertisement

  • Poster presentation
  • Open Access

A comprehensive approach to the central monitoring of clinical trials

  • 1,
  • 2,
  • 2 and
  • 2
Trials201516 (Suppl 2) :P173

https://doi.org/10.1186/1745-6215-16-S2-P173

  • Published:

Keywords

  • Monitoring Strategy
  • Informal Interview
  • Central Monitoring
  • Monitoring Plan
  • Clinical Trial Unit

Background

As part of a broader methodological programme of work around clinical trial monitoring, we plan to develop a comprehensive central monitoring strategy that is useful to staff developing clinical trial quality management and monitoring plans. In order to facilitate trial operation's staff planning a monitoring strategy where procedural and protocol compliance issues can be identified without the need to perform costly and intensive routine on-site data monitoring, we engaged in the current work that explores practical methods to achieve the aims of trial monitoring and trial conduct oversight.

Methods

The current work comprises of 3 components: a literature review; informal interviews and surveys of current practice by trial teams at a large UK Clinical Research Collaboration (UKCRC) registered Clinical Trials Unit engaging in phase II and III clinical trials in cancer and HIV research; and strategy development.

Results

At the time of writing this work is still being conducted. We aim to develop our strategy from the information available from all sources with suggestions for activities centred around: preventing, identifying, monitoring and addressing patient safety and participant rights issues; ensuring, through appropriate trial design and management, the generation of unbiased, accurate and timely data; enhancing trial management processes (including identifying poor performing sites and sites requiring additional support), enhancing protocol compliance, enhancing procedural compliance; and identifying fraudulent activities (fabrication or falsification of data).

Authors’ Affiliations

(1)
Comprehensive Clinical Trials Unit at UCL, London, UK
(2)
MRC Clinical Trials Unit at UCL, London, UK

Copyright

© Bakobaki et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement